Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
Simon J. Allison(University of Huddersfield), Roger M. Phillips(University of Bradford)
Cited by 142
Related Papers
Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands
|Cancer Letters|2017|67
Self-assembly of an anion receptor with metal-dependent kinase inhibition and potent in vitro anti-cancer properties
|Nature Communications|2021|62
Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors
|British Journal of Pharmacology|2013|33